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Data are presented on the formation of a linoleic acid oxygenation product under basal conditions by guinea 
pig alveolar macrophages (AM). Under non-stimulated conditions 20 x lo6 AM released about 1 nmol 
9-hydroxylinoleic acid (9-HODE) during a 15 min incubation. Furthermore, AM released more than 2 nmol 
12-hydroxy-5,8,10-heptadecatrienoic acid (HHT), a byproduct of the formation of thromboxane A, 
9-HODE and HHT were the most prominent products formed under the incubation conditions used. These 
products were formed via a cyclooxygenase-catalyzed reaction, since their formation was inhibited by 1 PM 
indomethacin. Thus, under basal conditions AM possess ubstantial cyclooxygenase activity. The biological 
significance of I)-HODE and related substances i  discussed. 
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1. INTRODUCTION 
Phagocytic cells represent an important defense 
mechanism in the lungs against inhaled foreign 
particles. In particular alveolar macrophages (AM) 
play an important role in the initial events of 
bacterial clearance [ 1,2]. Macrophages release 
various fatty acid metabolites, including pros- 
taglandins and leukotrienes, upon stimulation [3]. 
These fatty acid-derived mediators are crucial in 
the full development of the inflammatory 
response. In recent years emphasis has been placed 
on the production and the biological significance 
of arachidonic acid-derived mediators, including 
prostaglandins and leukotrienes. Macrophage 
membrane phospholipids, however, also contain 
linoleic acid which can be liberated by 
phospholipase activity upon cell stimulation [4]. 
Little information is available on the production of 
linoleic acid-derived mediators from inflammatory 
cells, and their possible role in the inflammatory 
Cyclooxygenase Enzyme activity Indomethacin 
process. We are the first to describe the release of 
9-hydroxylinoleic acid by AM under basal, i.e. 
non-stimulated, conditions from endogenous 
linoleic acid. The biological significance of this 
linoleate metabolite will be discussed. 
2. MATERIALS AND METHODS 
2.1. Isqlation and incubation of macrophages 
Alveolar macrophages were obtained from male 
Dunkin Hartley guinea pigs (400-600 g) through 
lung lavage in situ as described [5]. The 
macrophages were incubated at 20 x lo6 cells/ml 
in Krebs-bicarbonate solution for 15 min at 37’C. 
In one incubation 1 pM indomethacin was added 
at the start of the incubation period. After the in- 
cubation period the incubates were centrifuged at 
10000 x g for 15 min. The resulting supernatant 
was further subjected to extraction and fractiona- 
tion procedures as described below. 
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2.2. Extraction and analysis of fatty acid 
metabolites 
Supernatants of incubates were applied to 
disposable reverse-phase xtraction columns (J.T. 
Baker Chemicals, Deventer, The Netherlands), 
after which lipid-soluble material was eluted from 
the column with methanol. The methanol eluate 
was subsequently fractionated by silica gel 
chromatography according to [6], yielding frac- 
tions containing monohydroxy acids, dihydroxy 
acids, and prostaglandins, respectively. These frac- 
tions were initially analyzed by reverse-phase high- 
performance liquid chromatography (RP-HPLC) 
using a system to separate various leukotrienes and 
monohydroxy acids (system I) [7]. The HPLC ap- 
paratus consisted of a Pye Unicam PU4002 pump, 
PU4031 oven, and a PU4021 photodiode array 
detector. Chromatographic parameters and ana- 
lyses of results were controlled by a PU4850 
microcomputer. The analysis was performed at 
30°C on a Nucleosil X18 column (250 x 4.6 mm, 
Chrompack, Middelburg, The Netherlands) and 
the elution was carried out with tetrahydrofuran- 
methanol-water-acetic acid (25 : 30 : 45 : 0.1) (pH 
5.5 with ammonia). The aqueous phase contained 
0.1% EDTA. The flow rate was maintained at 
0.9 ml/min. The eluate was monitored in chro- 
mascan mode, in which a UV spectrum is taken 
every 1 s, resulting in a 3-dimensional plot of time 
and wavelength vs absorption. For identification 
purposes, a second RP-HPLC system was used, 
which separates monohydroxy acids (system II) 
[6], i.e. tetrahydrofuran-acetonitrile-water-acetic 
acid (22 : 40 : 38 : 0.05) at a flow rate of 1 .O ml/min. 
3. RESULTS 
RP-HPLC analysis of the incubation fluid of 
non-stimulated guinea pig AM revealed three fatty 
acid metabolites which were identified as 
HHT 
c 9-HODE 
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Fig.1. RP-HPLC analysis of an incubate of non-stimulated guinea pig AM (system I). This chromatogram is 
representative of the 4 analyses carried out. Monohydroxy acids were monitored at 235 nm. Synthetic prostaglandin 
Bz was used as an internal standard to correct for losses during the extraction procedures. 
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12-hydroxy-5,8, IO-heptadecatrienoic acid (HHT), 
13-hydroxy-9,l I-octadecadienoic acid (I3-HODE, 
13-hydroxylinoleic acid), and 9-hydroxy-10,12-oc- 
tadecadienoic acid (PHODE, 9-hydroxylinoleic 
acid), respectively (see fig.1). The three meta- 
bolites displayed maximal UV absorption at 
230 nm, indicative of monohydroxy acids. The 
HHT, 13-HODE and 9-HODE peaks coeluted 
with their respective authentic standards in silica 
gel fractionation (all compounds only present in 
the monohydroxy acids fraction), in RP-HPLC 
system I (retention time: 23, 41, 43 min, respec- 
tively), and in RP-HPLC system II (retention time: 
7, 11, 12 min, respectively). Formation of HHT 
and 9-HODE was totally inhibited by I FM indo- 
methacin, whereas 13-HODE formation was not. 
Eluting between the HHT and 13-HODE peaks, 
several peaks were seen which have not been iden- 
tified as yet. In an additional experiment he iden- 
tity of HHT and 9-HODE was further checked by 
labeling the macrophages with [3H]arachidonic 
acid for 45 min prior to the incubations. About 
60% of the added label was taken up by the cells. 
After collection of the HPLC eluate the HHT peak 
appeared to contain radioactivity, whereas the 
9-HODE peak did not. It was calculated that about 
1 nmol 9-HODE per 20 x IO6 cells was formed in 
the 15 min incubation period, whereas more than 
2 nmol HHT were formed (mean data from 4 ex- 
periments). In one experiment we observed that 
adhering macrophages, devoid of contaminating 
lymphocytes, also synthesized 9-HODE and HHT. 
We cannot exclude, however, that lymphocytes 
also produce these mediators. 
4. DISCUSSION 
Here, we have shown that under basal condi- 
tions guinea pig AM possess considerable cycloox- 
ygenase activity, as judged by the amount of HHT 
formed during a 15 min incubation. HHT is con- 
sidered to be formed concomitant with thrombox- 
ane AZ (TxAz) formation, which is catalyzed by 
cyclooxygenase and thromboxane synthase en- 
zymes [8,9]. Indeed, in additional experiments we 
also found TxB2, a stable breakdown product of 
TxA2, in incubates of AM (not shown). We also 
observed the formation of a linoleic acid 
metabolite, 9-HODE, by non-stimulated guinea 
pig AM. To our best knowledge no data are 
available in the literature on the release of 
9-HODE by inflammatory cells. Linoleic acid has 
been shown to be converted to monohydroxy 
metabolites by microsomal fractions from sheep 
seminal vesicles [lo], homogenates of VX2 car- 
cinoma tissue [l I], and by blood vessels [12]. The 
production of these metabolites could be inhibited 
by indomethacin, suggesting that they are formed 
through a cyclooxygenase-catalyzed reaction. In 
rabbit peritoneal tissue, however, only 9-HODE 
formation was clearly dependent on cycloox- 
ygenase activity, whereas 13-HODE was formed 
through lipoxygenase-like activity [ 131. In porcine 
leukocytes, 13-HODE was formed via a 
lipoxygenase-catalyzed reaction, since it could only 
be inhibited by the lipoxygenase inhibitor 
5,8,ll,lCeicosatetraynoic acid (ETYA) and not by 
indomethacin [6]. Our present results are in agree- 
ment with these findings, in that 9-HODE forma- 
tion by guinea pig AM could be inhibited by 
indomethacin. We also found small amounts of 
13-HODE, which was not affected by in- 
domethacin. It cannot be excluded that 13-HODE 
was formed by a lipoxygenase enzyme, although 
we could not detect the formation of any lipox- 
ygenase products from arachidonic acid in our in- 
cubations. It is equally possible that 13-HODE was 
formed non-enzymatically, since oxidation of 
linoleic acid in aqueous buffers favours the forma- 
tion of 13 positional isomers of the hydroxy acid 
[ 141. The fact that only limited information is 
available on the formation of linoleic acid 
metabolites by inflammatory cells can be explained 
by the experimental conditions usually employed 
in such studies. Most studies focus on the produc- 
tion of arachidonic acid-derived mediators, and 
exogenous arachidonic acid is added, or a stimulus 
is used which liberates arachidonic acid from mem- 
brane lipids. It has been shown, however, that 
arachidonic acid exerts a strong inhibition on the 
metabolism of linoleic acid [ 121. 
The biological significance of 9-HODE forma- 
tion is not known as yet. Structurally related 
monohydroxy derivatives of arachidonic acid 
(HETEs) exert a modulatory role on inflammatory 
processes, e.g. by interfering with the metabolism 
of arachidonic acid [15]. For example, 15-HETE 
inhibits 5- and IZlipoxygenase, whereas 5- and 
IZHETE inhibit 15-lipoxygenase. 13-HODE also 
has inhibitory properties towards 5-lipoxygenase 
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activity, albeit less than 15HETE [16]. HETEs 
have also been reported to stimulate chemotaxis 
and chemokinesis of neutrophils and eosinophils 
and to induce neutrophil aggregation and 
degranulation [ 17- 191. Whether 9-HODE has 
similar properties remains to be determined. Most 
interestingly, recent support for a role for 
monohydroxy acids in inflammatory processes has 
been obtained with patients with familial Mediter- 
ranean fever [20]. In these patients, who suffer 
from recurrent episodes of fever, serositis and ar- 
thritis, high levels of monohydroxy acids, in- 
cluding 9-HODE and 13-HODE, were found 
circulating in the blood. 
HETEs and HODEs are formed from their 
respective precursor fatty acids through a 
hydroperoxide intermediate. These hydroperox- 
ides may also have a modulatory function in the 
formation of fatty acid-derived mediators, either 
by providing the cyclooxygenase and lipoxygenase 
enzymes with the required peroxide tone [21], or 
by influencing phospholipase activity [22]. Other 
metabolites may be formed from linoleic acid as 
well, including epoxyhydroxy and trihydroxy 
derivatives [6,12]. Little is known about the 
biological significance of these products. In our in- 
cubations with AM we have not been able to detect 
any of these metabolites. Another interesting class 
of linoleic acid metabolites is produced by 
neutrophils and can also be found in rat lung 
lavage fluid after pure oxygen breathing [23,24], 
an experimental model to study inflammatory pro- 
cesses in the lungs. These epoxide derivatives, 
named leukotoxins, show a typical uncoupling ef- 
fect on mitochondrial respiration and relax rat 
stomach smooth muscle. 
In conclusion, it is evident hat besides the exten- 
sively studied arachidonic acid-derived prostaglan- 
dins and leukotrienes, linoleic acid-derived 
products may also be synthesized by inflammatory 
cells, and further research is necessary to 
acknowledge fully their possible role in inflam- 
matory processes. 
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